Biochemical mechanisms of drug action: what does it take for success?

Nature Reviews. Drug Discovery
David C Swinney

Abstract

Drug discovery is extremely difficult. There are many unanticipated scientific, medical and business challenges to every drug discovery programme. It is important to increase our understanding of the fundamental properties of effective drugs so that we can anticipate potential problems in developing new agents. This article addresses potential drug discovery and development risks associated with the biochemical mechanism of drug action, and proposes simple rules to minimize these risks.

References

Jan 1, 1977·Annual Review of Pharmacology and Toxicology·A Fleckenstein
Sep 1, 1975·The Journal of Clinical Investigation·G J Roth, P W Majerus
Mar 15, 1992·The Biochemical Journal·B CouetteM E Rafestin-Oblin
Apr 1, 1991·Journal of Cardiovascular Pharmacology·W G Nayler, X H Gu
Apr 1, 1990·The American Review of Respiratory Disease·R D KrellF J Brown
Jan 1, 1986·Journal of Steroid Biochemistry·A M BrodieR C Coombes
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·G SachsS Hersey
Jun 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·D P EdwardsC A Beck
Jan 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A CorsiniA L Catapano
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·R A CopelandJ M Trzaskos
Mar 8, 1996·The Journal of Biological Chemistry·A M Westley, J Westley
Feb 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·J D RabinowitzH M McConnell
Jun 17, 1998·The EMBO Journal·J FagartM E Rafestin-Oblin
Feb 7, 2001·Trends in Endocrinology and Metabolism : TEM·D P McDonnell
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·E L CunninghamD A Agard
Apr 27, 2001·Biochemical Pharmacology·F L FierensaG Vauquelin
May 8, 2001·Annual Review of Biophysics and Biomolecular Structure·A C SteinmetzD Moras
May 18, 2001·Journal of Medicinal Chemistry·C P MillerB S Komm
Aug 7, 2001·Frontiers in Bioscience : a Journal and Virtual Library·A P DennisZ Nawaz
May 10, 2002·The European Respiratory Journal·J A van NoordP J G Cornelissen
Aug 9, 2002·European Journal of Pharmacology·John C AnthesRobert E Egan
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Marc P MaillardMichel Burnier
Sep 5, 2002·Nature Reviews. Drug Discovery·Andrew L Hopkins, Colin R Groom
Feb 1, 2003·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Peter R Blower
Feb 7, 2003·Fundamental & Clinical Pharmacology·G VauquelinP M L Vanderheyden
Mar 1, 2003·Neurochemical Research·Mikael AngehagenElisabeth Hansson
Mar 20, 2003·Molecular Pharmacology·William F HoodJoseph B Monahan
Feb 11, 2004·Nature Immunology·Xiaolong Liu, Rémy Bosselut

❮ Previous
Next ❯

Citations

Aug 28, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Peter HeuslerDidier Cussac
Feb 15, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Georges VauquelinPhilip Seeman
Jun 18, 2009·Journal of Computer-aided Molecular Design·Lars NeumannDoris Hafenbradl
Jun 14, 2005·Advanced Drug Delivery Reviews·Michael T Black, John Hodgson
Jun 16, 2005·Current Opinion in Pharmacology·Paul Elvin, Andrew P Garner
Aug 25, 2009·Journal of the American Chemical Society·Lutz F TietzeIngrid Schuberth
Oct 27, 2012·Journal of Medicinal Chemistry·Christoph W ZapfQuintus G Medley
Dec 17, 2004·Nature·Christopher Lipinski, Andrew Hopkins
Aug 5, 2006·Nature Reviews. Drug Discovery·Robert A CopelandThomas D Meek
Oct 4, 2006·Nature Reviews. Drug Discovery·Peter ImmingAchim Meyer
Jun 28, 2011·Nature Reviews. Drug Discovery·David C Swinney, Jason Anthony
Jun 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ignasi BuchGianni De Fabritiis
Feb 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Fang BaiHualiang Jiang
Sep 7, 2007·Bioinformatics·Csaba HetényiMati Karelson
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Nina LiuPeter J Tonge
Jul 20, 2010·Future Medicinal Chemistry·Douglas S JohnsonBenjamin F Cravatt
Sep 3, 2011·Future Medicinal Chemistry·Robert A Copeland
Nov 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Adam W BarbPei Zhou
Aug 13, 2013·Journal of Pharmacological and Toxicological Methods·Huayun DengYe Fang
Oct 21, 2014·Future Medicinal Chemistry·Jamal El BakaliRebecca Deprez-Poulain
Nov 17, 2006·Nature Chemical Biology·Ian Collins, Paul Workman
Jan 6, 2011·Expert Opinion on Therapeutic Patents·Christopher J Burns, Andrew F Wilks
Jan 13, 2016·Expert Opinion on Drug Discovery·Adebayo A AdeniyiMahmoud E S Soliman
May 9, 2012·Expert Opinion on Drug Discovery·Vladimir N Uversky
Dec 1, 2006·Expert Opinion on Drug Discovery·David C Swinney
Feb 4, 2016·The Journal of Physical Chemistry. a·Tao GuoJiwen Zhang
Jun 15, 2010·Expert Opinion on Drug Discovery·Kay AhnBenjamin F Cravatt
Oct 1, 2006·Expert Opinion on Drug Discovery·Karl AnderssonMarkku D Hämäläinen
Aug 7, 2012·Expert Opinion on Drug Discovery·Ye Fang
Nov 1, 2010·Expert Opinion on Drug Discovery·Rumin Zhang, Frederick Monsma
Sep 27, 2014·Journal of Pharmaceutical Sciences·Arzu SelenJennifer B Dressman
Dec 19, 2015·Nature Reviews. Drug Discovery·Robert A Copeland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.